Table 2.

Odds of Dying at 3 and 24 Months With an Initial Acute Myocardial Infarction (AMI) According to Selected Factors

Characteristic	0–3 months		3–24 months
	OR*	95% CI	OR	95% CI
Age (years)
55–64	0.92	0.31,2.68	1.71	0.82,3.57
65–74	3.51	1.46,3.48	4.96	2.55,9.68
≥75	7.88	3.39,18.35	7.77	4.04,14.94
Male	1.40	1.02,1.93	1.34	1.02,1.76
White race	1.25	0.70,2.21	1.18	0.76,1.83
Length of stay	1.03	1.00,1.05	1.02	0.99,1.04
STEMI	0.81	0.56,1.18	0.53	0.38,0.73
Co-morbidities
Hypertension	0.72	0.50,1.04	0.92	0.67,1.28
Atrial fibrillation	1.31	0.86,2.02	0.60	0.41,0.87
Stroke	1.83	1.20,2.78	1.61	1.08,2.40
Heart failure	1.88	1.29,2.74	2.22	1.58,3.11
Diabetes	1.33	0.92,1.93	1.04	0.75,1.43
Kidney disease	1.65	1.11,2.45	1.31	0.90,1.91
In-hospital complications
Atrial	1.56	1.10,2.21	0.66	0.47,0.93
fibrillation
Heart failure	1.60	1.13,2.25	1.60	1.19,2.13
Cardiogenic	1.86	0.95,3.67	2.42	1.25,4.69
shock
Stroke	3.30	1.13,9.64	1.83	0.56,6.02
Hemorrhage	1.37	0.96,1.94	1.19	0.88,1.61
Physiologic variables
Systolic BP (mm Hg)
<100	1.76	1.03,3.03	1.16	0.67,2.04
120–139	0.79	0.50,1.27	0.84	0.56,1.27
140–159	0.67	0.42,1.08	0.59	0.39,0.88
≥160	0.60	0.38,0.96	0.74	0.50,1.08
Glomerular filtration rate (mL/min)
<30	1.65	0.97,2.79	4.14	2.59,6.64
30–59	1.19	0.82,1.73	1.41	1.04,1.91
Glucose (mg/dL)
<80	1.07	0.33,3.47	1.34	0.42,4.29
110–140	1.09	0.66,1.80	0.82	0.54,1.24
140–180	1.03	0.61,1.73	1.23	0.81,1.85
≥180	0.95	0.56,1.62	1.08	0.70,1.66

referent categories: age (<55 years), female, nonwhite, NSTEMI, absence of selected comorbidities, absence of selected hospital clinical complications, systolic BP 100–119 mmHg, eGFR ≥60 ml/min/1.73^m2, serum glucose 80–109 mg/dl

^*odds ratio